Peter Brandt

Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD.

Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA.

Epocrates LLC provides clinical tools and solutions. The firm provides the healthcare industry, primarily pharmaceutical companies, and opportunities to engage with its user network through delivery of targeted information and to conduct market research. The company was founded by Richard Fiedotin and Jeff Tangney on August 1998 and is headquartered in San Mateo, CA.

Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL.

Pfizer Health Solutions, Inc. develops and implements health technology solutions. It develops and implements clinical technology solutions. The company was founded on August 3, 2000 and is headquartered in New York, NY.

Founded in 1998, Epocrates, Inc. Research is an investment research firm located in Ewing, New Jersey. The firm is a subsidiary of Epocrates, Inc. (NasdaqGM: EPOC), a San Mateo, California-based company that develops clinical information and decision support tools for healthcare professionals.